FDA accelerates drug approval for patients with aggressive breast cancers

Proper BCS greatergood_ctg_belowtitle

EmaxHealth Health News

By Robin Wulffson MD for eMaxHealth.com

New Food and Drug Administration (FDA) guidelines were released this week that grant accelerated approval of new drugs for use in women with aggressive, early-stage breast cancers. The approval was granted in the hope that their use might give them the best chance for a cure drug.

The decision will allow pharmaceutical manufacturers to test the drugs on a few months before they undergo breast cancer surgery, instead of waiting until the medication has been proven first in seriously ill patients. The FDA is accepting comments about its draft plan through the end of July.

Learn more.

Veteran and His Loyal Dog Pass Away Within Hours Of Each Other: Click “Next” below!

The Breast Cancer Site is a place where supporters and survivors come together to help fight breast cancer. In addition to sharing personal stories of hope, shopping for the cause, and signing petitions, visitors can take just a moment each day to click on a pink button to provide free mammograms for women in need. Visit The Breast Cancer Site and click today - it's free!
Proper greatergood_ctg_belowcontent